Investigation of a patient with a partial trisomy 16q including the fat mass and obesity associated gene (FTO): Fine mapping and FTO gene expression study

American Journal of Medical Genetics, Part A

Volumn 152, Issue 3, 2010, Pages 630-637

  Van Berg, Linda Den ^a,b   De Waal, Henriette Delemarre Van ^a   Han, Joan C ^c   Ylstra, Bauke ^b   Eijk, Paul ^b   Nesterova, Maria ^c   Heutink, Peter ^b   Stratakis, Constantine A ^c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

16q duplication; ADHD; BBS2; CGH; FTO; Imprinting; Obesity; qPCR; SLC6A2

Indexed keywords

GENOMIC DNA;

ADULT; ARTICLE; CASE REPORT; CHROMOSOME 16Q; COMPARATIVE GENOMIC HYBRIDIZATION; DNA MICROARRAY; FAT MASS AND OBESITY ASSOCIATED GENE; FEMALE; GENE; GENE DUPLICATION; GENE EXPRESSION; GENE MAPPING; HUMAN; HUMAN CELL; LYMPHOCYTE; OBESITY; PARTIAL TRISOMY; PARTIAL TRISOMY 16Q; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BASE SEQUENCE; BREAST; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 16; COMPARATIVE GENOMIC HYBRIDIZATION; DNA PRIMERS; FEMALE; GENE DOSAGE; GENE EXPRESSION; HUMANS; LYMPHOCYTES; OBESITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEINS; TRISOMY;

EID: 77649223723     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.33229     Document Type: Article

References (34)

1. Barber JCK, Zhang S, Friend N, Collins AL, Maloney VK, Hastings R, Farren B, Barnicoat A, Polityko AD, Rumyantseva NV, Starke H, Ye S. 2006. Duplications of proximal 16q flanked by heterochromatin are not euchromatic variants and show no evidence of heterochromatic position effect. Cytogenet Genome Res 114:351-358.
2. Biederman J, Spencer T. 1999. Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol Psychiatry 46:1234-1242.
3. Boissel S, Reish O, Proulx K, Kawagoe-Takaki H, Sedgwick B, Yeo GS, Meyre D, Golzio C, Molinari F, Kadhom N, Etchevers HC, Saudek V, Farooqi IS, Froguel P, Lindahl T, O'Rahilly S, Munnich A, Colleaux L. 2009. Loss-of-function mutation in the dioxygenase-encoding FTO gene causes severe growth retardation and multiple malformations. Am J Hum Genet. 85:106-111.
4. Brisset S, Joly G, Ozilou C, Lapierre J-M, Gosset P, LeLorc'h M, Raoul O, Turleau C, Vekemans M, Romana SP. 2002. Molecular characterization of partial trisomy 16q24.1-qter: Clinical report and review of the literature. Am J Med Genet 113:339-345.
5. Buffart TE, Israeli D, Tijssen M, Vosse SJ, Mršić A, Meijer GA, Ylstra B. 2008. Across array comparative genomic hybridization: A strategy to reduce reference channel hybridizations. Genes Chromosomes Cancer 47:994-1004.
6. Chen CP, Lee CC, Wang W. 2004. Prenatal diagnosis of complete trisomy 16q in two consecutive pregnancies. Prenat Diagn 24:1019-1020.
7. Chen CP, Lin SP, Lin CC, Li YC, Chern SR, Chen WM, Lee CC, Hsieh LJ, Wang W. 2005. Perinatal findings and molecular cytogenetic analysis of de novo partial trisomy 16q (16q22.1→qter) and partial monosomy 20q (20q13.3→qter). Prenat Diagn 25:112-118.
8. den Dunnen JT, Antonarakis SE. 2001. Nomenclature for the description of human sequence variations. Hum Genet 109:121-124.
9. Dina C, Meyre D, Gallina S, Durand E, Korner A, Jacobson P, Carlsson LM, Kiess W, Vatin V, Lecoeur C, Delplanque J, Vaillant E, Pattou F, Ruiz J, Weill J, Levy-Marchal C, Horber F, Potoczna N, Hercberg S, Le Stunff C, Bougneres P, Kovacs P, Marre M, Balkau B, Cauchi S, Chevre JC, Froguel P. 2007. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet 39:724-726.
10. Engelen JJ, De Die-Smulders CE, Vos PT, Meers LE, Albrechts JC, Hamers AJ. 1999. Characterization of a partial trisomy 16q with FISH. Report of a patient and review of the literature. Ann Genet 42:101-104.
11. Fischer J, Koch L, Emmerling C, Vierkotten J, Peters T, Brüning JC, Rüther U. 2009. Inactivation of the Fto gene protects from obesity. Nature 458:894-898.
12. Fleisch AL. 1951. Le metabolisme basal standard et sa determination au moyen du "metabocalculator". Helv Med Acta 18:23-44.
13. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, Perry JR, Elliott KS, Lango H, Rayner NW, Shields B, Harries LW, Barrett JC, Ellard S, Groves CJ, Knight B, Patch AM, Ness AR, Ebrahim S, Lawlor DA, Ring SM, Ben-Shlomo Y, Jarvelin MR, Sovio U, Bennett AJ, Melzer D, Ferrucci L, Loos RJ, Barroso I, Wareham NJ, Karpe F, Owen KR, Cardon LR, Walker M, Hitman GA, Palmer CN, Doney AS, Morris AD, Smith GD, Hattersley AT, McCarthy MI. 2007. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316:889-894.
14. Fryns JP. 1990. Follow-up of 16q deletions. Am J Med Genet 37:510.
15. Gustavsson P, Schoumans J, Staaf J, Borg A, Nordenskjöld M, Annerén G. 2007. Duplication 16q12.1-q22.1 characterized by array CGH in a girl with spina bifida. Eur J Med Genet 50:237-241.
16. Harris JA, Benedict FG. 1919. A biometric study of basal metabolism in man. Washington, DC: Carnegie Institution of Washington. Hatanaka K, Ozaki M, Suzuki M, Murata R, Fujita H. 1984. Trisomy 16q13!qter in a infant from a t(11;16)(q25;q13) translocation-carrier father. Hum Genet 65:311-315.
17. Hoebeeck J, Speleman F, Vandesompele J. 2007. Real-time quantitative PCR as an alternative to Southern blot or fluorescence in situ hybridization for detection of gene copy number changes. Methods Mol Biol 353:205-226.
18. Houlston RS, Renshaw RM, James RS, Ironton R, Temple IK. 1994. Duplication of 16q22→qter confirmed by fluorescence in situ hybridisation and molecular analysis. J Med Genet 31:884-887.
19. Lee C, Iafrate AJ, Brothman AR. 2007. Copy number variations and clinical cytogenetic diagnosis of constitutional disorders. Nat Genet 39:S48-S54.
20. Mascarello JT, Hubbard V. 1991. Routine use of methods for improved Gband resolution in a population of patients with malformations and developmental delay. Am J Med Genet 38:37-42.
21. Masuno M, Ishii T, Tanaka Y, Ohyama M, Kawataki M, Kimura J, Imaizumi K, Kuroki Y. 2000. De novo trisomy 16p11.2-qter: Report of an infant. Am J Med Genet 92:308-310.
22. Mizuno Y, Sotomaru Y, Katsuzawa Y, Kono T, Meguro M, Oshimura M, Kawai J, Tomaru Y, Kiyosawa H, Nikaido I, Amanuma H, Hayashizaki Y, Okazaki Y. 2002. Asb4, Ata3, and Dcn are novel imprinted genes identified by high-throughput screening using RIKEN cDNA microarray. Biochem Biophys Res Commun 290:1499-1505.
23. Nikaido I, Saito C, Wakamoto A, Tomaru Y, Arakawa T, Hayashizaki Y, Okazaki Y. 2004. EICO (Expression-based Imprint Candidate Organizer): Finding disease-related imprinted genes. Nucleic Acids Res 32:D548-D551.
24. Nishimura DY, Searby CC, Carmi R, Elbedour K, Van Maldergem L, Fulton AB, Lam BL, Powell BR, Swiderski RE, Bugge KE, Haider NB, Kwitek-Black AE, Ying L, Duhl DM, Gorman SW, Heon E, Iannaccone A, Bonneau D, Biesecker LG, Jacobson SG, Stone EM, Sheffield VC. 2001. Positional cloning of a novel gene on chromosome 16q causing Bardet-Biedl syndrome (BBS2). Hum Mol Genet 10:865-874.
25. Ren H, Francis W, Boys A, Chueh AC, Wong N, La P, Wong LH, Ryan J, Slater HR, Andy Choo KH. 2005. BAC-based PCR fragment microarray: High-resolution detection of chromosomal deletion and duplication breakpoints. Hum Mutat 25:476-482.
26. Ridler MA, McKeown JA. 1979. Trisomy 16q arising from a maternal 15p;16q translocation. J Med Genet 16:317-320.
27. Romain DR, Frazer AG, Columbano-Green LM, Parfitt RG, Smythe RH, Chapman CJ. 1984. Direct intrachromosomal duplication of 16q and heritable fragile site fra (10) (q25) in the same patient. Am J Med Genet 19:507-513.
28. Spraggs CF, Pillai SG, Dow D, Douglas C, McCarthy L, Manasco PK, Stubbins M, Roses AD. 2005. Pharmacogenetics and obesity: Common gene variants influence weight loss response of the norepinephrine/ dopamine transporter inhibitor GW320659 in obese subjects. Pharmacogenet Genomics 15:883-889.
29. Stratakis CA, Lin JP, Rennert OM. 1998. Description of a large kindred with autosomal dominant inheritance of branchial arch anomalies, hearing loss, and ear pits, and exclusion of the branchio-oto-renal (BOR) syndrome gene locus (chromosome 8q13.3). Am J Med Genet 79: 209-214.
30. Stratakis CA, Lafferty A, Taymans SE, Gafni RI, Meck JM, Blancato J. 2000. Anisomastia associated with interstitial duplication of chromosome 16, mental retardation, obesity, dysmorphic facies, and digital anomalies: Molecular mapping of a new syndrome by fluorescent in situ hybridization and microsatellites to 16q13 (D16S419-D16S503). J Clin Endocrinol Metab 85:3396-3401.
31. Stratigopoulos G, Padilla SL, LeDuc CA, Watson E, Hattersley AT, Mc-Carthy MI, Zeltser LM, Chung WK, Leibel RL. 2008. Regulation of Fto/ Ftm gene expression in mice and humans. Am J Physiol Regul Integr Comp Physiol 294:R1185-R1196.
32. Trimborn M, Wegner R-D, Tönnies H, Sarioglu N, Albig M, Neitzel H. 2006. Prenatal diagnosis and molecular cytogenetic characterisation of a small de novo interstitial duplication 16q11.2-q13. Prenat Diagn 26:273-276.
33. Verma RS, Kleyman SM, Conte RA. 1997. Variant euchromatic band within 16q12.1. Clin Genet 52:446-447.
34. Wing MR, Ziegler J, Langefeld CD, Ng MC, Haffner SM, Norris JM, Goodarzi MO, Bowden DW. 2009. Analysis of FTO gene variants with measures of obesity and glucose homeostasis in the IRAS Family Study. Hum Genet. 125:615-626.